AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|
16.1 C
New York
Thursday, October 22, 2026

Tag: executive

newsFORsourcecompanycontentinformation1releasesmarket

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy 

TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026. 

Simplilearn and Carahsoft Partner to Bring AI and Digital Skills Training to the U.S. Public Sector

Live, Boot Camp-Style Training Now Available to Federal, State and Local Government AgenciesPLANO, Texas and RESTON, Va., June 10, 2026 /PRNewswire/ -- Simplilearn, a...

Simplilearn and Carahsoft Partner to Bring AI and Digital Skills Training to the U.S. Public Sector

Live, Boot Camp-Style Training Now Available to Federal, State and Local Government AgenciesPLANO, Texas and RESTON, Va., June 10, 2026 /PRNewswire/ -- Simplilearn, a...

High Tide to Open Two New Canna Cabana Locations in Welland and Calgary

CALGARY, AB, June 10, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward...

GameChange Energy Named #1 Solar Tracker Company in India, Africa, and APAC, #2 Globally, by Wood Mackenzie

NORWALK, Conn., June 10, 2026 /PRNewswire/ -- GameChange Energy, a global energy infrastructure company, announced that it has been ranked the world's second-largest solar tracker...

PTC Unveils a Wave of Product Innovations to Give Manufacturers New AI Capabilities and Connected Tools Across the Intelligent Product Lifecycle

Introduces PTC Orbit and PTC Jetstream, a new AI platform, 12 AI agents, 10 new integrations, and 100+ enhancements across CAD, PLM, ALM, and...

Caylent Signs Multi-Year Strategic Collaboration Agreement with AWS to Accelerate AI Innovation, Customer Experience Transformation, and Agentic Cloud Operations

Expanded collaboration will fuel Caylent's agentic AI practice, newly formed Amazon Connect practice anchored by the Pronetx acquisition, and managed services model through agentic...

The American Kennel Club/AKC Canine Health Foundation Announce First Cornell Sports Medicine & Rehabilitation Resident

RALEIGH, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- The AKC Canine Health Foundation (CHF), in collaboration with the American Kennel Club (AKC®), is pleased to announce that the Cornell University College of Veterinary Medicine has matched its first resident funded through the second annual AKC/AKC CHF Canine Sports Medicine & Rehabilitation Residency Program award. Dr. Gabriela Medrano will begin her training with the program this fall.

Fedora Pharmaceuticals Expands Scientific Advisory Board with Appointment of Drs. Michael Dudley, Keith Micetich, and Jürgen Bulitta

Drs. Michael N. Dudley, Keith A. Micetich, and Jürgen B. Bulitta join advisory board of renowned infectious disease leaders at Fedora Pharmaceuticals.

Decisions of the repeat Annual General Meeting of AS Pro Kapital Grupp shareholders

The repeat annual shareholders general meeting (hereinafter referred to as the Meeting) of AS Pro Kapital Grupp (hereinafter referred to as the Company) took place on Wednesday, 10th of June 2026 starting at 12.30 at the premises of the Company at Sõjakooli 11 in Tallinn, Estonia.

Decisions of the repeat Annual General Meeting of AS Pro Kapital Grupp shareholders

The repeat annual shareholders general meeting (hereinafter referred to as the Meeting) of AS Pro Kapital Grupp (hereinafter referred to as the Company) took place on Wednesday, 10th of June 2026 starting at 12.30 at the premises of the Company at Sõjakooli 11 in Tallinn, Estonia.

weR and RGIS Expand Strategic Collaboration to Accelerate AI-Powered Retail Shelf Intelligence Across Europe and the United States

NEW YORK, June 10, 2026 /PRNewswire/ -- Following successful validation with leading global retailers and enterprise partners across Europe and the United States, weR...

From Team Member to Vice President: Express Wash Concepts Promotes Adam Opalka to Lead Retail Operations

COLUMBUS, Ohio, June 10, 2026 /PRNewswire/ -- Express Wash Concepts (EWC), one of the nation's fastest-growing express car wash operators, today announced the promotion of...

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

Access the segment here

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsExecutive

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers